This position statement provides updated consensus recommendations for antiplatelet therapy specifically tailored to East Asian patients with coronary artery disease.
Answers are grounded in this paper and cite their sources.
Updates antiplatelet choices for East Asian CAD patients; extends prior guidelines with ethnicity-specific consensus.
inhibitors observed in this population. This consensus update focuses on the latest progress and hotspot issues on antiplatelet therapy in the East Asian population with coronary artery disease and therapeutic recommendations based on the best available evidence.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: